REGN Trial readout: Monday, November 2, 2026
EventTrial readout
DateMonday, November 2, 2026
MarketUS listing
SourceCT.gov registry · confidence 50% · primary source ↗
Est. Completion: 2026-11-02. Status: ACTIVE_NOT_RECRUITING. Title: A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma
Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.
Every date on this page is free — forever.
A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.